May 20, 2020
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
Apr 21, 2020
Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer's Markets
Feb 06, 2020
Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research
Jan 27, 2020
Pacific Neuroscience Institute Offers Final Enrollment into Important Clinical Trial for Patients with Lewy Body Dementia
Nov 07, 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Oct 08, 2019
ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy
Sep 23, 2019
Michael J. Fox Foundation Announces $10-million "Ken Griffin Alpha-synuclein Imaging Competition" Spurring Development of Critical and Elusive Research Tool for Parkinson's Disease
Jul 12, 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Jul 10, 2019
The Lewy Body Dementia Resource Center is Hosting an Exclusive Private Screening and Reception of Robin's Wish at Lincoln Center in New York
Jun 24, 2019
Enterin's DEMET Study Enrolls First Patient With Parkinson's Disease Dementia (PDD)
Jun 04, 2019
New Virtual Reality Immersive Learning Lab on Lewy Body Dementia with Parkinson's Disease Transforms Health Care Training and Family Caregiver Education
May 23, 2019
APRINOIA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research
Apr 15, 2019
EIP Pharma Closes $11.2 Million Financing Round to Advance Development of Neflamapimod in Additional Neurodegenerative Disease Indications
Mar 19, 2019
ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson's Disease at AD/PD(TM) 2019 Conference
Mar 13, 2019
BioArctic Announces Start of Phase 1 Study of ABBV-0805 for Parkinson's Disease
Mar 07, 2019
StressMarq Biosciences Inc. PCT Patent Application for a Novel Antibody Therapeutic Candidate to Combat Parkinson's Disease is Published
Feb 22, 2019
AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies
Dec 14, 2018
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
Nov 20, 2018
ProMIS Neurosciences Issues Year-to Date Update, Highlighting 2018 Accomplishments
Nov 13, 2018
United Neuroscience Strengthens Vaccine Pipeline with Novel Immunotherapy for Parkinson's Disease